188 related articles for article (PubMed ID: 37875978)
1. The effect of zofenopril on the cardiovascular system of spontaneously hypertensive rats treated with the ACE2 inhibitor MLN-4760.
Cacanyiova S; Cebova M; Simko F; Baka T; Bernatova I; Kluknavsky M; Zorad S; Krskova K; Shaman E; Zemancikova A; Barta A; Aydemir BG; Berenyiova A
Biol Res; 2023 Oct; 56(1):55. PubMed ID: 37875978
[TBL] [Abstract][Full Text] [Related]
2. Hydrogen sulfide accounts for the peripheral vascular effects of zofenopril independently of ACE inhibition.
Bucci M; Vellecco V; Cantalupo A; Brancaleone V; Zhou Z; Evangelista S; Calderone V; Papapetropoulos A; Cirino G
Cardiovasc Res; 2014 Apr; 102(1):138-47. PubMed ID: 24501330
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular changes in spontaneously hypertensive rats are improved by chronic treatment with zofenopril.
Gómez-Roso M; Montero MJ; Carrón R; Sevilla MA
Br J Pharmacol; 2009 Dec; 158(8):1911-21. PubMed ID: 19917062
[TBL] [Abstract][Full Text] [Related]
4. Vascular Effects of Low-Dose ACE2 Inhibitor MLN-4760-Benefit or Detriment in Essential Hypertension?
Berenyiova A; Bernatova I; Zemancikova A; Drobna M; Cebova M; Golas S; Balis P; Liskova S; Valaskova Z; Krskova K; Zorad S; Dayar E; Cacanyiova S
Biomedicines; 2021 Dec; 10(1):. PubMed ID: 35052717
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin System Modulations in Spontaneously Hypertensive Rats and Consequences on Erythrocyte Properties; Action of MLN-4760 and Zofenopril.
Jasenovec T; Radosinska D; Kollarova M; Balis P; Dayar E; Bernatova I; Zorad S; Vrbjar N; Cacanyova S; Radosinska J
Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944718
[TBL] [Abstract][Full Text] [Related]
6. Zofenopril exerts a cardiovascular protective effect on rats infused with angiotensin II beyond angiotensin-converting enzyme inhibition.
Gómez-Roso M; Montero MJ; Carrón R; Sevilla MA
J Pharm Pharmacol; 2016 Nov; 68(11):1422-1429. PubMed ID: 27670145
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen Sulphide Release via the Angiotensin Converting Enzyme Inhibitor Zofenopril Prevents Intimal Hyperplasia in Human Vein Segments and in a Mouse Model of Carotid Artery Stenosis.
Macabrey D; Deslarzes-Dubuis C; Longchamp A; Lambelet M; Ozaki CK; Corpataux JM; Allagnat F; Déglise S
Eur J Vasc Endovasc Surg; 2022 Feb; 63(2):336-346. PubMed ID: 34916111
[TBL] [Abstract][Full Text] [Related]
8. Zofenopril Protects Against Myocardial Ischemia-Reperfusion Injury by Increasing Nitric Oxide and Hydrogen Sulfide Bioavailability.
Donnarumma E; Ali MJ; Rushing AM; Scarborough AL; Bradley JM; Organ CL; Islam KN; Polhemus DJ; Evangelista S; Cirino G; Jenkins JS; Patel RA; Lefer DJ; Goodchild TT
J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27381758
[TBL] [Abstract][Full Text] [Related]
9. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM
Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
[TBL] [Abstract][Full Text] [Related]
10. MLN-4760 Induces Oxidative Stress without Blood Pressure and Behavioural Alterations in SHRs: Roles of
Kluknavsky M; Micurova A; Cebova M; Şaman E; Cacanyiova S; Bernatova I
Antioxidants (Basel); 2022 Dec; 11(12):. PubMed ID: 36552591
[TBL] [Abstract][Full Text] [Related]
11. Murine recombinant angiotensin-converting enzyme 2: effect on angiotensin II-dependent hypertension and distinctive angiotensin-converting enzyme 2 inhibitor characteristics on rodent and human angiotensin-converting enzyme 2.
Ye M; Wysocki J; Gonzalez-Pacheco FR; Salem M; Evora K; Garcia-Halpin L; Poglitsch M; Schuster M; Batlle D
Hypertension; 2012 Sep; 60(3):730-40. PubMed ID: 22777933
[TBL] [Abstract][Full Text] [Related]
12. Converting enzyme inhibition after experimental myocardial infarction in rats: comparative study between spirapril and zofenopril.
van Wijngaarden J; Pinto YM; van Gilst WH; de Graeff PA; de Langen CD; Wesseling H
Cardiovasc Res; 1991 Nov; 25(11):936-42. PubMed ID: 1813122
[TBL] [Abstract][Full Text] [Related]
13. AHU377+Valsartan (LCZ696) Modulates Renin-Angiotensin System (RAS) in the Cardiac of Female Spontaneously Hypertensive Rats Compared With Valsartan.
Zhao Y; Ma R; Yu X; Li N; Zhao X; Yu J
J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):450-459. PubMed ID: 31023080
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker treatment and haemodynamic factors are associated with increased cardiac mRNA expression of angiotensin-converting enzyme 2 in patients with cardiovascular disease.
Lebek S; Tafelmeier M; Messmann R; Provaznik Z; Schmid C; Maier LS; Birner C; Arzt M; Wagner S
Eur J Heart Fail; 2020 Dec; 22(12):2248-2257. PubMed ID: 33017071
[TBL] [Abstract][Full Text] [Related]
15. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
Westendorp B; Schoemaker RG; van Gilst WH; van Veldhuisen DJ; Buikema H
Eur J Pharmacol; 2005 Dec; 527(1-3):141-9. PubMed ID: 16310764
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of angiotensin-converting enzyme 2 exacerbates cardiac hypertrophy and fibrosis in Ren-2 hypertensive rats.
Trask AJ; Groban L; Westwood BM; Varagic J; Ganten D; Gallagher PE; Chappell MC; Ferrario CM
Am J Hypertens; 2010 Jun; 23(6):687-93. PubMed ID: 20300067
[TBL] [Abstract][Full Text] [Related]
17. Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients.
Pasini AF; Garbin U; Nava MC; Stranieri C; Pellegrini M; Boccioletti V; Luchetta ML; Fabrizzi P; Lo Cascio V; Cominacini L
Am J Hypertens; 2007 Apr; 20(4):443-50. PubMed ID: 17386354
[TBL] [Abstract][Full Text] [Related]
18. Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension.
Napoli C; Sica V; de Nigris F; Pignalosa O; Condorelli M; Ignarro LJ; Liguori A
Am Heart J; 2004 Jul; 148(1):e5. PubMed ID: 15215814
[TBL] [Abstract][Full Text] [Related]
19. Cardioprotective effects of zofenopril, a new angiotensin-converting enzyme inhibitor, on doxorubicin-induced cardiotoxicity in the rat.
Sacco G; Bigioni M; Evangelista S; Goso C; Manzini S; Maggi CA
Eur J Pharmacol; 2001 Feb; 414(1):71-8. PubMed ID: 11230997
[TBL] [Abstract][Full Text] [Related]
20. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
Paull JR; Widdop RE
J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
